EmaxHealth

Health knowledge and news provided by doctors.

Ads by Google

Heart

The most important part of the body human heart is a muscular organ that pumps approximately 2,000 gallons of blood per day throughout human body. Learn about the latest signs and symptoms of various heart related diseases and new treatment options.

Atrium Medical Corporation Announces First Implant Of CINATRA Coronary Stent

Atrium Medical has begun enrollment of the first patients for their CONFIRM 1, First-in-Man (FIM) drug eluting coronary stent clinical trial. Atrium's European FIM clinical trial study is evaluating Atrium's CINATRA voclosporin coated coronary stent system.

conditions: 

Blood Test Could Indicate Higher Risk For Coronary Event

A research study has found that a simple blood test may indicate whether post-menopausal hormone therapies present an elevated risk of a heart attack. The study, part of the Women's Health Initiative (WHI), sponsored by the National Heart, Lung and Blood Institute of the National Institutes of Health, was conducted in 40 centers nationwide and included 271 cases of coronary heart disease in the first four years of the trials of estrogen alone and of estrogen plus progestin. Corresponding author Paul F.

conditions: 

FDA Approves First Compact Heart Assist Device

Heart assist devices are surgically implanted mechanical pumps that help the heart's ventricle do its work of pumping blood to the rest of the body. Previous models were too large to be placed in the upper abdomen of some women and small-sized men. But the Thoratec HeartMate II Left Ventricular Assist System employs a first-of-a-kind design. Instead of the standard pulsatile pump that simulates the action of the heart, the device uses a continuous flow pump that constantly moves blood with a single moving part, a spinning rotor.

conditions: 

Boston Scientific Receives Approval For TAXUS Liberte Stent System

Boston Scientific Corporation has received approval for the sale of its TAXUS Liberte paclitaxel-eluting coronary stent system in Canada. The Company reported that Health Canada's Therapeutic Products Directorate (TPD), the authority that regulates pharmaceutical drugs and medical devices, has approved its use. The Company said it plans to launch the product immediately in Canada.

conditions: 

In Blood Vessel Stents Innovative Materials Allow Better Control

Before gene therapy becomes practical for treating human diseases, researchers must master the details of safe and effective delivery. Cardiology researchers at The Children's Hospital of Philadelphia have advanced delivery techniques by creating a versatile synthetic material that can bind to a variety of gene therapy vectors and can be custom-designed for controlled local release of therapeutic genes at a disease site.

conditions: 

Pages